Penn Medicine Provider
Radiation Oncology
Steven Joel Feigenberg, MD
4.9
(150)
Accepting new patients
Sees patients age 18 and up
Penn Radiation Oncology Perelman-Concourse Level

About me

  • Chief, Thoracic Service, Radiation Oncology
  • Professor of Radiation Oncology at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: Drexel University College of Medicine
  • Residency: Temple University Hospital
  • Residency: University of Florida Health System - Shands

What my patients think about me

Average Rating
4.9

150 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

May 2025
5.0
5.0
good job!
May 2025
5.0
5.0
he is wonderful
April 2025
5.0
5.0
informative and good humor
April 2025
5.0
5.0
just great service

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Feigenberg is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Verginadis, Ioannis I., Deborah E. Citrin, Bonnie Ky, Steven J. Feigenberg, Alexandros G. Georgakilas, Christine E. Hill-Kayser, Constantinos Koumenis, Amit Maity, Jeffrey D. Bradley, and Alexander Lin Radiotherapy toxicities: mechanisms, management, and future directions , The Lancet : 2025


Long M, Alnoury M, Udupa JK, Tong Y, Wu C, Poole N, Mannikeri S, Ky B, Feigenberg SJ, Zou JW, O’Reilly S Prediction of Radiation Therapy Induced Cardiovascular Toxicity from Pretreatment CT Images in Patients with Thoracic Malignancy via an Optimal Biomarker Approach , Academic Radiology: 2025


Sang Ho Lee, Nikhil Yegya-Raman, Richard Caruana, Jeffrey Bradley, Gary Kao, Steven Feigenberg, Ying Xiao Multitask Double Machine Learning for Counterfactual Estimation of Survival and Toxicity in Locally Advanced NSCLC Chemoradiotherapy , International Journal of Radiation Oncology • Biology • Physics : 2025


Melanie Berger, Cole Friedes, Nikhil Yegya-Raman, William Levin, Keith Cengel, Jeffrey Bradley, Steven Feigenberg, Michelle Iocolano Patterns of Failure and Toxicity in Patients with N2 vs. N3 Disease Undergoing Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer , ASTRO's Red Journal: 2025


Long M, Alnoury M, Udupa JK, Tong Y, Wu C, Poole N, Mannikeri S, Ky B, Feigenberg SJ, Zou JW, O’Reilly S, Torigian DA Prediction of radiation therapy induced cardiovascular toxicity from pretreatment CT images in patients with thoracic malignancy via an optimal biomarker approach , Acad Radiol: 2025


McMillan, Matthew T., Steven Joel Feigenberg, and Charles B. Simone Current Approaches to Radiation Oncology Target Volume Delineation Using PET/Computed Tomography , PET clinics : 2025


Feigenberg, Steven J., Stephen J. Hunt, Abass Alavi, and Charles B. Simone Current and Developing Applications of PET in Radiation Oncology , PET clinics: 2025


Fan, Yong, Steven Joel Feigenberg, and Charles B. Simone Current and Future Applications of PET Radiomics in Radiation Oncology. , PET clinics: 2025


Feigenberg, Steven J., Francesca Costabile, Ceylan Tanes, Kyle Bittinger, Roddy O’Connor, Divyansh Agarwal, Giorgos Skoufos et al Immune System Modulation with Oral Vancomycin in combination with Stereotactic Body Radiotherapy (SBRT) for medically inoperable Early-Stage Non-small Cell Lung Cancer , medRxiv : 2025


M Sharma, C Friedes, C Hollawell, DA Alexander, JW Zou, Y Xiao, W Levin, JD Bradley, N Yegya-Raman, SJ Feigenberg and BKK Teo Quality-of-life Metrics Correlate with Dual-energy and 4D CT Derived Perfusion and Ventilation In Lung Cancer Patients 6 months Post Radiation Therapy , Red Journal: 2025